ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2943

Severity of Foot Pain Is Linked to the Prevalence of Depressive Symptoms: The Framingham Foot Study

Arunima Awale1, Alyssa B. Dufour2, Patricia P. Katz3, Virginia A. Casey1 and Marian T. Hannan4, 1Institute for Aging Research, Hebrew SeniorLife, Boston, MA, 2Institute for Aging Research, Hebrew SeniorLife, Harvard Medical School & Beth Israel Deaconess Medical Center, Boston, MA, 3Medicine, University of California, San Francisco, CA, 4Institute for Aging Research, Hebrew SeniorLife, Dept. of Medicine Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: depression, foot and pain

  • Tweet
  • Email
  • Print
Session Information

Title: Epidemiology/Public Health

Session Type: Abstract Submissions (ARHP)

Background/Purpose:

While a number of risk factors for foot pain are established, the relation between depression and foot pain has not been well studied. The purpose of this study was to examine the associations of foot pain and severity of foot pain with depressive symptoms in a population-based study of older adults.

Methods:

A validated foot assessment and the 20-item CES-D questionnaire were administered to Framingham Foot Study (2002-08) participants. Age (years) and body mass index (BMI, kg/m2) were also collected. Foot pain was queried: “On most days, do you have pain, aching or stiffness in either of your feet?” Severity of foot pain was categorized as: none (referent), mild, moderate or severe pain. CES-D scores ≥ 16 were considered indicative of significant level of depressive symptoms. Sex-specific logistic regression was used to calculate odds ratios and 95% confidence intervals for the association of foot pain (y/n or severity of foot pain) with depressive symptoms (y/n) adjusting for age and BMI. In a subset of participants, further models adjusted for leg pain (hip, knee, ankle), back pain, or other joint pain (neck, shoulder, elbow, wrist).        

Results:

Of the 3321 participants (mean age: 66 ± 10 years), 1464 were men (BMI: 28.9 ± 4.7 kg/m2) and 1857 were women (BMI: 28.0 ± 6.0 kg/m2). 21% men and 27% women had depressive symptoms (CES-D score ≥ 16). Men with moderate foot pain vs. none had 2-fold increased odds (Table) of reporting depressive symptoms; men with severe foot pain had a 4-fold increased odds, independent of age and BMI. Women showed a similar trend in which women with moderate foot pain had 2-fold increased odds of depressive symptoms, and women with severe foot pain had 3-fold odds, independent of age and BMI. For both men and women, mild foot pain showed increased odds (ratios of = 1.3 and 1.4 respectively), but was only statistically significant for women (p = .046).  Models considering other regions of pain attenuated the odds ratios (Table); pain variables were non-significant for men, while in women, back pain (p = .007), other pain (p = .019) but not leg pain (p = .775) added to the model.

Conclusion:

Severity of foot pain, adjusting for age and BMI, was significantly associated with the prevalence of depressive symptoms in our study (i.e., those reporting worse foot pain were more likely to report depressive symptoms). Adding joint pain at other regions attenuated but did not change the pattern of results. Future studies should investigate the longitudinal aspects of the severity of foot pain and depressive symptoms in older adults.

Table: Odds ratios and 95% confidence intervals for the association between severity of foot pain and depressive symptoms, stratified by sex, and adjusted for age and BMI.*

 

Men (n = 1464)

Women (n = 1857)

 

n (%)

OR (CI)

n (%)

OR (CI)

Foot pain (y/n)

277 (19)

1.84 (1.36, 2.48)

543 (29)

1.93 (1.55, 2.45)

Severity

 

 

 

 

    No foot pain (referent)

1187 (81)

1.0

1314 (71)

1.0

    Mild foot pain

114 (8)

1.26 (0.79, 2.02)

208 (11)

1.40 (1.01, 1.94)

    Moderate foot pain

126 (9)

1.88 (1.25, 2.86)

233 (13)

2.09 (1.55, 2.82)

    Severe foot pain

37 (2)

4.34 (2.26, 8.48)

102 (5)

3.08 (2.02, 4.68)

 

 

 

 

 

Models further adjusted for leg pain, back pain and other joint pain.

 

n (%)

OR (CI)

n (%)

OR (CI)

Foot pain (y/n)

198 (21)

1.56 (1.09, 2.23)

370 (31)

1.54 (1.17, 2.06)

Severity

 

 

 

 

    No foot pain (referent)

746 (79)

1.0

824 (69)

1.0

    Mild foot pain

87 (9)

0.91 (0.54, 1.55)

141 (12)

1.08 (0.73, 1.59)

    Moderate foot pain

81 (9)

1.87 (1.14, 3.06)

152 (13)

1.69 (1.16, 2.45)

    Severe foot pain

30 (3)

3.64 (1.71, 7.75)

77 (6)

2.53 (1.54, 4.15)

  *Depressive symptoms dichotomized as CES-D score ≥ 16 or <16.


Disclosure:

A. Awale,
None;

A. B. Dufour,
None;

P. P. Katz,
None;

V. A. Casey,
None;

M. T. Hannan,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/severity-of-foot-pain-is-linked-to-the-prevalence-of-depressive-symptoms-the-framingham-foot-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology